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Mannose-binding lectin (MBL) is an integral part of the innate immune system and functions as an opsonin by
binding to pathogens and certain apoptotic cells to promote their uptake by phagocytes. We recently identiﬁed an
association of low-producing MBL polymorphisms with adult dermatomyositis (DM). Our model is that MBL de-
ﬁciency leads to a defect in the clearance of apoptotic debris in the skin, thereby predisposing to photosensitive
autoimmune disease. In this study, we sought to determine whether MBL binds within the epidermis, and to
determine its source, and potential function of this binding. We demonstrated that the MBL is present in irradiated,
but not in non-irradiated skin, and in irradiated skin it is bound to apoptotic keratinocytes (KC). We found that MBL
is not made by KC, showing indirectly that it comes from an exogenous source, despite the fact that other com-
plement components are made by KC and upregulated by ultraviolet irradiation. Finally, we demonstrated that non-
KC-derived MBL bound to apoptotic KC in vitro and increased the uptake of these cells by dendritic cells. We
hypothesize that MBL may facilitate non-inﬂammatory clearance of apoptotic debris in patients with photosensitive
forms of DM.
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Mannose-binding lectin (MBL) is an integral part of the in-
nate immune system. It is part of a family of proteins known
as collectins, which include surfactant protein A (SpA) and
surfactant protein D (SpD) (Holmskov et al, 2003). These
proteins are structurally homologous to early complement
component C1q and similarly contain a globular head with
repetitive carbohydrate recognition domains (CRD) and a
collagenous tail with collagen repeats. Like C1q, MBL ac-
tivates complement, although in an antibody-independent
fashion. MBL binds to a wide spectrum of oligosaccharides
on the surface of invading pathogens to activate the clas-
sical or alternative complement pathway (Ikeda et al 1987;
Lu et al, 1990; Ohta et al, 1990; Matsushita et al, 2000; Neth
et al, 2000). It also functions as an opsonin by binding to
pathogens and promoting uptake by phagocytes (Kuhlman
et al, 1989; Neth et al, 2000). Binding is likely mediated
through the CRD on the globular calcium-dependent lectin
domain (Drickamer et al, 1986; Ezekowitz et al, 1988; Thiel
and Reid, 1989) that recognizes fucose, mannose, or glu-
cose.
MBL circulates in the plasma as a mixture of oligomers,
ranging from trimers to hexamers. Three structural poly-
morphisms that interrupt the integrity of the collagen re-
peats have been identified. These include changes at
codons 52, 54, and 57 (Madsen et al, 1994). Polymorph-
isms in the promoter region result in three haplotypes, HX,
LX, and LY. These polymorphisms result in high, medium,
and low levels of circulating protein, respectively (Madsen
et al, 1995). MBL deficiency is associated with an opsonic
defect and increased infections (Super et al, 1989; Sumiya
et al, 1991; Summerfield et al, 1995) and autoimmune dis-
ease in some populations (Davies et al, 1995; Senaldi et al,
1995; Lau et al, 1996; Sullivan et al, 1996).
MBL is known to bind to apoptotic Jurkat T cells, pe-
ripheral blood mononuclear cell, and human umbilical vein
endothelial cells (HUVEC) and to receptors on the surface of
macrophages, suggesting that it may play a role in clearing
apoptotic cells (Ogden et al, 2001; Nauta et al, 2003).
Skin biopsies from patients with photosensitive autoim-
mune diseases, such as dermatomyositis (DM) and subcu-
taneous lupus erythematosus (SCLE), are characterized by
increased numbers of apoptotic keratinocytes (KC) (Pablos
et al, 1999). We recently identified that low-producing MBL
polymorphisms are associated with DM (Werth et al, 2002a).
Ultraviolet (UV) light induces KC apoptosis (Schwarz et al,
1995) and translocation of intracellular antigens to distinct
blebs on the cell surface (Casciola-Rosen et al, 1994).
These blebs contain lupus autoantigens, including nu-
1Portions of this work were presented at the 2003 Annual Sci-
entific Sessions of the Society for Investigative Dermatology and
published in abstract form: Mannose binding lectin in UV-irradiated
skin. J Invest Dermatol 121:77, 2003 (abstr).
Abbreviations: DC, dendritic cells; HMDC, human monocyte-de-
rived dendritic cells; KC, keratinocytes; MBL, mannose-binding
lectin; MED, minimal erythematous dose; MFI, mean fluoresence
intensity; mRNA, messenger RNA; TAMRA,5-(&6)-carboxytetrame-
thylrhodamine, succinimidyl ester; TBST, tris-buffered saline with
1% Tween 20; TNF-a, tumor necrosis factor-a; UVA, ultraviolet A;
UVB, ultraviolet B
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
166
cleosomal DNA, Ro, and La, in two distinct populations
(Casciola-Rosen et al, 1994). MBL and other collectins have
been shown to bind directly to DNA (Palaniyar et al, 2004). A
deficiency in MBL may therefore lead to a buildup of apo-
ptotic debris in the skin and predispose to development of
autoimmune photosensitive disease.
In this study, we characterize the binding of MBL to KC
in vivo and in vitro, demonstrating that MBL binds to irradi-
ated apoptotic KC. We also demonstrate that the MBL
comes from an exogenous source, despite the fact that other
complement components are made by KC and upregulated
with UV irradiation (Dovezenski et al, 1992; Terui et al, 2000).
Non-KC-derived MBL binds to apoptotic KC and may facil-
itate non-inflammatory clearance of apoptotic debris.
Results
Increased MBL on apoptotic KC in vivo after ultraviolet
B (UVB) irradiation MBL was detected on the surface of
apoptotic KC in the epidermis from a wild-type MBL subject
at 48 h after UVB exposure. More MBL was detected in 2.5
minimal erythematous dose (MED)-irradiated skin relative to
sham (Fig 1a, b) and more MBL staining using the 1C10
antibody was detected at the 48 h time point than at either
the 24 or 72 h time points (data not shown). Cleaved ca-
spase-3 is an early apoptotic marker. In contrast to C1q,
which has been demonstrated to bind predominantly to late
apoptotic cells (Nauta et al, 2002), we found MBL staining
on the early apoptotic cells, as indicated by co-localization
of the MBL staining with caspase-3-positive cells (Fig 1a, c).
Control MOPC21 antibody did not bind to either UV- or
sham-irradiated skin (data not shown). UVB-irradiated apo-
ptotic KC stained with 1C10 anti-MBL antibody in the pres-
ence of exogenous MBL (Fig 2a, b). The red MBL staining
pattern was punctate on the cell surface, as exhibited by a
composite view with the deconvoluted image (Fig 2a), and
co-localized only with fluorescein isothiocyanate (FITC)-
labeled annexin positive apoptotic KC (Fig 2b). Nuclear
staining with diamidinophenyl indole (DAPI) (blue) defines
the cell location. No MBL staining was seen in irradiated KC
without exogenous MBL (Fig 2c) or in sham-irradiated KC
with added MBL (Fig 2d).
MBL is not made by sham- or UV-irradiated KC MBL is a
serum protein, but recent reports have demonstrated or
Figure 1
Increased mannose-binding lectin (MBL) is on the surface of apoptotic cells. Normal skin was irradiated with 2.5 minimal erythematous dose or
sham. Biopsies were taken at 48 h. Tissue was then stained with MBL detected with Texas Red (a, b), and cleaved caspase-3 detected by
fluorescein isothiocyanate (c, d). MBL was detected with antibody 1C10. Cleaved caspase-3 is a marker of early apoptosis. There is punctate cell
staining that co-localizes with early apoptotic marker cleaved caspase-3 (arrows). Scale bar¼ 25 mm.
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suggested that monocytes, and mature and immature den-
dritic cells (DC) are a source of MBL (Ogden et al, 2001;
Downing et al, 2003). To confirm the absence of synthesis of
MBL by KC, we examined KC messenger RNA (mRNA) and
protein production of MBL, as well as the presence of MBL
in KC medium. No mRNA for MBL was detected in either
UVB- or ultraviolet A- (UVA-) irradiated neonatal KC at 24 h,
whereas the control hepatic HUH7 cell line was positive for
MBL mRNA (Fig 3). A time course performed with UVB-
irradiated neonatal KC, with RNA harvested 0, 3, 6, or 24 h
after UVB irradiation, showed no MBL mRNA, but message
was detected in positive control HUH7 cells (Fig 3). Tumor
necrosis factor-a (TNF-a) mRNA, measured as another pos-
itive control for RT-PCR, was detected in the KC. UVA-ir-
radiated neonatal KC also showed no MBL mRNA (data not
shown). To confirm that MBL was not present in the system
at earlier time points, we performed a standard enzyme-
linked immunoabsorbent assay (ELISA) on conditioned
medium after 3, 6, 16, and 24 h of culture. MBL was not
detected at any time point nor in the medium alone. Human
serum was used as a positive control (Fig 4). This demon-
strates that neither MBL protein nor mRNA is produced by
resting or irradiated cultured KC.
MBL increases uptake of apoptotic KC by DC Uptake of
apoptotic 5-(&6)-carboxytetramethylrhodamine, succinimi-
dyl ester (TAMRA)-labeled KC by human monocyte-derived
DC (HMDC) was measured using fluorescence-activated
cell sorting (FACS) analysis. Addition of 10 mg rMBL per mL
increased phagocytosis to 2.1 times the no-MBL control
(Fig 5). This experiment was performed three times, and the
results are expressed as the mean  SEM of the three dif-
ferent experiments (po0.05).
MBL does not effect maturation of DC To study the pos-
sible effects of MBL on DC maturation, maturation markers
of human leukocyte antigen (HLA)-DR and CD83 were used
to compare lipopolysaccharide (LPS)-induced maturation
versus MBL effects on maturation. After 24-h incubation
with LPS, HLA-DR expression was induced  300% com-
Figure 2
Mannose-binding lectin (MBL) binds to apoptotic keratinocytes (KC). When exogenous MBL is added, MBL is detected on the cell surface of
ultraviolet B (UVB)-irradiated KC counterstained with diamidinophenyl indole (DAPI) to visualize the nucleus (a, MBL is Texas red; DAPI is blue).
These same cells are apoptotic, as demonstrated by annexin V-positive staining (b, annexin is green; DAPI is blue). No staining is seen in irradiated
KC without added MBL (c) or sham-irradiated KC with added MBL (d).
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pared with immature HMDC (75.67–224.71 (mean fluores-
cence intensity, MFI)), and CD83 expression was induced to
368% compared with immature HMDC (45.57–171.30 MFI).
Incubation with MBL increased surface expression of HLA-
DR and CD83 by 10% and 4%, respectively, 75.67–83.59
MFI and 46.57–49.70 MFI, respectively.
Discussion
In this study, we demonstrate that MBL binds to UVB-irra-
diated apoptotic KC in vivo. We found that MBL is not pro-
duced by KC. We suggest a possible function of MBL in the
clearance of apoptotic cells by demonstrating that addition
of MBL to apoptotic KC in vitro increases phagocytosis by
HMDC.
There is growing evidence that the inefficient removal of
apoptotic and necrotic cellular debris promotes inflamma-
tion and the production of autoantibodies (Rovere et al,
2000; Walport, 2000). Recently, there has been an effort to
uncover the mechanisms by which apoptotic cells are re-
moved in a non-immunogenic fashion. UV light is a common
trigger of DM; increased amounts of apoptotic cells are
present in skin biopsies from these patients (Pablos et al,
1999). A deficiency in clearance may predispose to the de-
velopment of these diseases by allowing uptake of apopto-
tic cells by immature DC, which would then process them
and present the epitopes to autoreactive T lymphocytes
(Rovere et al, 2000).
In the past, we focused on the development of apoptotic
KC from the photoinduction of TNF-a. UV light B increases
the production of TNF-a in the presence of interleukin (IL) 1a
or b (Werth and Zhang, 1999) and TNF-a is involved in the
production of apoptotic KC (Schwarz et al, 1995). We have
Figure 3
Lack of detectable mannose-binding lectin (MBL) messenger RNA
(mRNA) at any time point after irradiation of human neonatal ker-
atinocytes in vitro. Lanes 1–4 correspond to 0, 3, 6, and 24 h after
ultraviolet B irradiation (30 mJ per cm2). Lane 5 is a positive MBL mRNA
control (HUH7 RNA). Tumor necrosis factor- (TNF-) a mRNA, measured
as a positive control for reverse transcriptase-polymerase chain reac-
tion, was detected at all time points (0–24 h).
Figure4
Lack of detectable mannose-binding lectin (MBL) protein in con-
ditioned medium from ultraviolet B-irradiated keratinocytes (KC).
KC were irradiated and the supernatant was harvested at 3, 6, 16, and
24 h. Human serum (positive control) shows the presence of MBL. No
MBL protein was detected in the culture supernatant or medium.
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Figure5
Mannose-binding lectin (MBL) increases uptake of apoptotic ker-
atinocytes by human monocyte-derived dendritic cells (HMDC).
The uptake of 5-(&6)-carboxytetramethylrhodamine, succinimidyl ester-
labeled, annexin V-positive keratinocytes by HMDC is expressed as the
times increase relative to no MBL. Uptake increased with the addition
of MBL (10 mg per mL). The results are expressed as the mean  SEM
of three independent experiments. po0.05.
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demonstrated that an overproducing polymorphism at the
308 promoter region of TNF-a gene is associated with
SCLE ((Werth et al, 2000) and DM (Werth et al, 2002b). Re-
cently, we found that low-producing MBL polymorphisms
are more common in patients with DM compared with nor-
mal controls (Werth et al, 2002a). Based on prior literature
and these results, we suggest that the absence of MBL may
be important in the pathogenesis of DM by modulating the
immune response to irradiated apoptotic KC. We demon-
strate this by showing that MBL binds to the surface of
apoptotic KC and enhances uptake by DC. Our working
model is that this interaction is important for the non-in-
flammatory clearance of apoptotic cells and the prevention
of the production of autoantibodies.
There are many lines of evidence to support this model.
First, deficiency of MBL and structurally homologous C1q
predispose to autoimmune disease in certain populations
(Bowness et al, 1994; Davies et al, 1995; Lau et al, 1996;
Sullivan et al, 1996). Second, in C1q knockout mice, auto-
immune disease is characterized by the presence of mul-
tiple glomerular apoptotic bodies (Botto et al, 1998). Third,
MBL and C1q are each sufficient for the uptake of apoptotic
cells by phagocytes (Bobak et al, 1987; Tenner et al, 1995;
Ogden et al, 2001). Studies have demonstrated that MBL
and C1q bind to the surface of apoptotic Jurkat T cells,
monocytes, and HUVEC in the region of cellular membrane
blebs (Korb and Ahearn, 1997; Ogden et al, 2001; Nauta
et al, 2002; Downing et al, 2003). C1q binds to KC (Korb and
Ahearn, 1997). This binding has been demonstrated to oc-
cur in the region of the globular head of the protein (Ogden
et al, 2001; Nauta et al, 2002). It has also been demon-
strated that they bind to phagocytes through their colla-
genous tails (Bobak et al, 1987; Ogden et al, 2001). Our data
reported here support that MBL is binding to apoptotic KC.
Many groups have demonstrated that MBL binds to the
same ligand on macrophages as C1q (Tenner et al, 1995;
Nepomuceno et al, 1997). MBL and C1q have been dem-
onstrated to bind to the C1qR, or calreticulin, receptor, on
the surface of macrophages (Peerschke and Ghebrehiwet,
1987; Malhotra et al, 1990; Guan et al, 1991; Malhotra et al,
1993). The combination of calreticulin and CD91, or a-2-
macroglobulin, promotes macropinocytosis of the apoptotic
cell (Ogden et al, 2001). Other groups have identified a
common receptor known as the C1qRp, a 126 kDa type I
membrane protein (Guan et al, 1994; Nepomuceno et al,
1997).
MBL may also modulate the immune response by cre-
ating the right environment to allow uptake of apoptotic
debris by scavenger phagocytes (Rovere et al, 2000). MBL
has been demonstrated to suppress TNF-a production (So-
ell et al, 1995). TNF-a predisposes the monocyte to mature
to an antigen-presenting cell (Rovere et al, 2000). Therefore,
in the absence of MBL, there will be more activated antigen-
presenting cells, thereby predisposing to the uptake and
presentation of apoptotic epitopes to the immune system.
Liver cells produce MBL (Holmskov, 2003). Other groups
suggest that monocytes may be a source of MBL (Ogden
et al, 2001; Downing et al, 2003). We now present evidence
that KC do not produce MBL. We demonstrate that MBL
binds to apoptotic KC and we suggest that this interaction
is important for directing the non-inflammatory uptake of
apoptotic debris. Lack of MBL may therefore predispose to
DM by allowing persistence of apoptotic debris, enhanced
antigen presentation, and subsequent development of
autoimmunity.
Materials and Methods
Human subject All human studies were approved by the Univer-
sity of Pennsylvania Institutional Review Board (Protocol #701676).
Written, informed consent was obtained for all procedures and
information was collected, and the study was conducted accord-
ing to the Declaration of Helsinki Principles. One individual was
selected from the University of Pennsylvania dermatology clinic.
Criteria for selection included absence of a photosensitizing con-
dition or medication. MBL genotype was wild type for structural
and promoter polymorphisms, to ensure normal serum MBL levels.
Phototesting The subject was initially tested on the lower back for
MED by receiving 8 1-cm2 area spots of UVB [290–320] in in-
creasing increments of 25% using a broadband UVB light box
(Ultralight, Laurenceville, Georgia) filtered with a cellulose triacetate
filter to remove all wavelengths below 290 nm, as previously de-
scribed (Werth and Zhang, 1999). The filtered UVB light source
measured by spectroradiometric measurement at the time of the
experiments showed 52.45% UVB. UVB doses were measured
with an International light UV IL-443 UVB meter (International Light
Enterprises, Newburyport, Massachusetts). At 24 h, MED was de-
termined by identifying the lowest dose of UVB that turned the
exposed area completely erythematous. The subject was then ex-
posed to three 1-cm2 area spots of a dose 2.5 times the MED, as
well as to an area of sham irradiation. Four-millimeter punch bi-
opsies were taken of the UV- and sham-irradiated sites at 24, 48,
and 72 h. Biopsies were immediately embedded in OCT embed-
ding medium (Tissue-Tek, Torrence, California), and stored at
701C until use.
Figure 6
Mannose-binding lectin (MBL) does not effect human monocyte-
derived dendritic cell (HMDC) maturation. Two maturation markers,
human leukocyte antigen (HLA)-DR (a) and CD83 (b), show maturation
of HMDC with lipopolysaccharide, but not with MBL. iDC, immature
dendritic cells; mDC, mature dendritic cells.
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Cell culture and UV irradiation in vitro Primary neonatal foreskin
KC were grown according to a standard protocol (Chen and Jen-
sen, 1996), using MCDB 152 Medium Complete (Sigma) supple-
mented with amino acids. Cells were grown to 90% confluence in
tissue culture plates coated with rat collagen (0.5 mg per mL). For
MBL, mRNA and protein determinations, 30-mm dishes with 90%
confluent neonatal KC were irradiated with 30 mJ per cm2 of UVB,
followed by harvesting of supernatant and/or mRNA at 0, 3, 6, and
24 h for mRNA and 3, 6, 16, and 24 h for protein. The UVB source
was a bank of two FS-40 sunlamps (Light of America, Walnut,
California) with a peak irradiance of 313 nm, and a cellulose tri-
acetate filter that removes wavelengths below 290 nm. UVB doses
were measured with an International light UV IL-443 UVB meter.
The filtered UVB light source measured by spectroradiometric
measurement at the time of the experiments showed 0.64% UVC,
44.51% UVB, 19.43% UVA, and 35.42% visible and near infrared.
HUH7 cells, a human hepatoma cell line known to make MBL
(a kind gift from Dr John M. Taylor, Fox Chase Cancer Center,
Philadelphia, Pennsylvania), were grown in 10% fetal calf serum
(FCS) in Dulbeccos minimal essential medium (DMEM). The A431-
transformed KC line was obtained from the ATCC (Bethesda, Mar-
yland) and grown in DMEM with 10% FCS.
Immunohistochemistry of skin Four-micrometer sections of hu-
man skin were stained within 24 h of sectioning. As MBL binding to
sugar substrates is calcium dependent, all washes were performed
in tris-buffered saline (TBS) with 10 mM of CaCl2 (Downing et al,
2003). Three 5-min washes were performed between every step.
We characterized and optimized the binding of mouse anti-human
MBL antibody 1C10 (Isotype IgG2b, a kind gift from Gregory Stahl,
Brigham & Women’s Hospital, Boston, Massachusetts) (Collard
et al, 2000). Using the same binding and washing conditions, we
found that a second monoclonal anti-MBL antibody, HYB-131-01
(Antibody Shop, Denmark), exhibited staining of cultured human
keratinocytes (HK) that had no detectable MBL protein or mRNA,
suggesting a non-specific interaction. Thus, we chose the 1C10
antibody for all reported studies. Antibody MOPC21 (Isotype IgG1-
k, Sigma-Aldrich, St Louis, Missouri, Cat. No. M9269) was used as
a control antibody. We identified apoptotic cells with rabbit anti-
human cleaved caspase-3 (Cell Signaling, Cat. # 9661), as well as
terminal deoxynucleotidyl transferase-mediated dUTP in situ nick
end-labeling staining (Roche Molecular Biochemicals, Mannheim,
Germany. #1767291).
To simultaneously examine the localization of apoptotic cells
and MBL staining, the tissue was fixed in acetone for 2 min at
201C, and then blocked with 1.5% bovine serum albumin for
15 min at room temperature. Sections were then incubated at 41C
overnight in a humidified chamber with 1C10 (50 mg per mL) in TBS
supplemented with 10 mM CaCl2. Approximately 18 h later, the
sections were incubated overnight at 41 with a 1:50 dilution of
rabbit anti-cleaved caspase-3. A mixture of secondary antibodies
at 1:1600 was incubated for 1.5 h at room temperature (Alexa Fluor
594 goat anti-mouse and Alexa Fluor 488 donkey anti-rabbit IgG,
Molecular Probes, Eugene, Oregon, cat # A-11005 and A-21206).
After washing, all slides were mounted with Vectashield mount-
ing medium for fluorescence (H-1000 Vector, Burlingame, Califor-
nia). Slides were viewed under a fluorescent microscope (Olympus
BX6, Olympus America, Melville, New York), and images were tak-
en at  40 using ProGres Digital Imaging.
Immunohistochemistry of KC Primary KC were sham and UVB
irradiated (120 mJ per cm2), and then incubated in medium. At 16 h
post-irradiation, cells were incubated in medium with or without
10 mg per mL of recombinant MBL (a gift from Alan Ezekowitz,
Massachusetts General Hospital, Boston, Massachusetts) for 1 h
at 371C. Sixteen hours after irradiation, detached KC were har-
vested and washed twice with TBS with 1% Tween 20 (TBST) with
5 mM CaCl2 (50 mM Tris, 150 mM NaCl, 1% Tween, pH 7.5), and
preparation of cytospin slides was performed. FITC-labeled an-
nexin V (5 mL per 100 mL staining buffer, Caltag Laboratories,
Burlingame, California) was added to the cells in staining buffer (10
mm N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid/NaOH,
140 mM NaCl, 2.5 mM CaCl2, pH 7.4) for 15 min at room tem-
perature. After air-drying, cells were fixed with cold acetone
(201C) for 30 s. Cells were blocked with 10% donkey serum in
TBST-Ca for 10 min at room temperature. They were then incu-
bated with monoclonal 1C10 anti-MBL antibody (10 mg per mL) for
1.5 h at room temperature, followed by Alexa Fluor 594 donkey
anti-mouse IgG (1:3000, Molecular Probes) in TBST-Ca, and coun-
terstained with DAPI Nuclei Acid Stain (300 nM in phosphate-buff-
ered saline, Molecular Probes). All washes were performed with
TBST with 5 mM CaCl2 (50 mM Tris, 150 mM NaCl, 1% Tween, pH
7.5). Slides were then mounted with Vectashield mounting medium
for fluorescence (H-1000 Vector, Burlingame, California) for 5 min
at room temperature. The Alexa Fluor was visualized with the Texas
red filter, the annexin with a FITC filter, and the DAPI with the UV
filter. Cells were visualized and photographs were obtained using a
Nikon Eclipse TE 2000E at  40 using Image Pro Plus software.
Deconvolution was performed using AutoBlur and Autovisualize v.
9.2 (Watervliet, New York, New York).
DNA analysis DNA was isolated from anticoagulated blood ac-
cording to standard protocols (PUREGENE, Gentra systems, Min-
neapolis, Minnesota). Genotyping of the subject was performed by
polymerase chain reactions (PCR) using allele-specific primers for
MBL (Sullivan et al, 1996).
MBL ELISA Conditioned media from irradiated and sham-irradi-
ated cells were collected 24 h after irradiation. MBL was quantit-
ated by commercial ELISA (Serum Statens Institute, Copenhagen,
Denmark). It is stated that this antibody has specificity for MBL
from human serum/plasma. Sera from a person with wild-type
MBL genotype were used as a positive control.
RNA isolation and reverse transcriptase-PCR (RT-PCR) Total
RNA was extracted using Trizol (Invitrogen, Carlsbad, California), a
monophase solution containing guanidine thiocyanate and phenol.
Five micrograms (5 mg) of total RNA from HK, A431 cells, and
hepatoma cell line (HUH7) was reverse transcribed by using Su-
perscript Reverse Transcriptase (Invitrogen). Equal volumes (3 mL)
of first-strand complementary DNA were amplified for MBL along
with TNF-a as a control for RT-PCR of HK cells. The oligonucleo-
tide primer sequence for MBL (GI:4557738) and TNF-a (GI:37219)
are as follows: MBL sense (50-ATGTCCCTGTTTCCATCACT-30);
MBL antisense (50-TCAGATAGGGAACTCACAGACGG-30); TNF-a
sense (50-GCCCTGGTATGAGCCCATCTATCTG-30); and TNF-a an-
tisense (50-CAATGATCCCAAAGTAGACCTGC-30). The amplifica-
tion products of MBL (747 bp) and TNF-a (131 bp) were resolved
by electrophoresis on 1.5% agarose gel and visualized by ethidium
bromide staining.
Phagocytosis assays
Isolation of human DC HMDC were obtained from normal human
peripheral blood monocytes isolated from fresh leucocyte-en-
riched buffy coats from different normal donors. Cells were placed
in 24-well tissue culture plates in serum-free, AIM-V Medium (Gib-
co Grand Island, New York, New York). Non-adherent cells were
aspirated after 2 h of culture, and the adherent cells were cultured
with 50 ng per mL of granulocyte macrophage-colony stimulating
factor and IL-4 (50 ng per mL) (R&D Systems, Minneapolis,
Minnesota) for 6–7 d. The DC were then used for apoptotic and DC
maturation assays.
Labeling of KC with TAMRA A431-transformed KC were plated
into 60-mm tissue culture plates and incubated for 2 d at 371C, 5%
CO2 until confluent, and were then incubated with 50 mg of viable
dye, TAMRA (Molecular Probes) for 15 min at 371C, as previously
described (Hess et al, 1997). The KC were washed, and apoptosis
of more than 90% of cells was induced by UVB irradiation (60 mJ
per cm2). Cells were harvested at 6 h and confirmed to be apo-
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ptotic by surface morphology as demonstrated by surface mem-
brane blebbing stained with TAMRA and by FITC-labeled annexin V
binding (10 mL per 5.5  106 cells, Caltag Laboratories). Prominent
blebbing was demonstrated, and subsequent FACS staining dem-
onstrated both TAMRA and annexin V staining of these cells. Re-
combinant MBL was added (10 mg per mL) for 30 min at 371C, 5%
CO2, and then washed once with TBS–5mM CaCl2.
Phagocytosis assay TAMRA-labeled apoptotic KC, with and with-
out exogenous MBL, were added to HMDC derived from 50 mL
peripheral blood grown in AIM-V Medium. Apoptotic or normal KC
were added to HMDC at a ratio of 1:5, respectively, for 60 min at
371C. HMDC were labeled with anti-CD11c–FITC (Caltag) after
phagocytosis. After 1 h, cells were harvested and analyzed by flow
cytometry on a FACs Calibur (Becton Dickinson, San Jose, Cal-
ifornia). FACS analysis was used to examine the percentage of
CD11c-positive DC that bound or ingested TAMRA-labeled apo-
ptotic KC (double-positive DC).
DC maturation HMDC were incubated with 10 mg per mL of re-
combinant MBL or 100 ng per mL LPS for 24 h to study the pos-
sible effects of MBL on DC maturation. DC maturation markers,
HLA-DR and CD83, were used to compare LPS-induced matura-
tion versus MBL effects on maturation. After 24 h of incubation with
either MBL or LPS, HMDC were harvested and labeled with lineage
1 cocktail-FITC (CD3, CD14, CD16, CD19, CD20, CD56) (Becton
Dickinson), anti-CD11c-PE (Caltag), anti-HLA-DR (Becton Dickon-
son), and anti-CD83-APC (Caltag). Cells were harvested and
analyzed by flow cytometry on a FACs Calibur (Becton Dickin-
son). Using logical gating, cells that were lineage 1 dim and anti-
CD11c positive were analyzed for maturation markers.
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